EVIDENCES FOR THE PROMISING THERAPEUTIC POTENTIAL OF BOSWELLIA SERRATA AGAINST ALZHEIMER'S DISEASE: PRE-CLINICAL STUDY

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Pharmacy and Pharmaceutical Sciences

• Publication date

  2014-10-29

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• AMELIORATION OF NEUROINFLAMMATION AND APOPTOSIS CHARACTERIZING ALZHEIMER'S DISEASE BY NATURAL PRODUCTS

  2013cited by this paper
• Possible Therapeutic Uses of Salvia triloba and Piper nigrum in Alzheimer's Disease–Induced Rats

  2013cited by this paper
• Modulation of the immune system by Boswellia serrata extracts and boswellic acids.

  2010cited by this paper
• The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.

  2010cited by this paper
• The effects of Tabernaemontana divaricata root extract on amyloid beta-peptide 25-35 peptides induced cognitive deficits in mice.

  2010cited by this paper
• Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease.

  2009cited by this paper
• [Effect of aluminium on neural behavior and the expression of Bcl-2 and Fas in hippocampus of weaning rats].

  2009cited by this paper
• Some anticancer medicinal plants of foreign origin

  2009cited by this paper
• Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain.

  2009cited by this paper
• Crystal Structures of the Choline/Acetylcholine Substrate-binding Protein ChoX from Sinorhizobium meliloti in the Liganded and Unliganded-Closed States*

  2008cited by this paper
• Boswellic Acids with Acetylcholinesterase Inhibitory Properties from Frankincense

  2008cited by this paper
• Effect of Long-Term Exposure to Aluminum on the Acetylcholinesterase Activity in the Central Nervous System and Erythrocytes

  2008cited by this paper
• Comparison of Several Groups

  2008cited by this paper
• Metabolism of Boswellic Acids in Vitro and in Vivo

  2008cited by this paper
• Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain.

  2008cited by this paper
• Flavonoids with iNOS inhibitory activity from Pogonatherum crinitum.

  2008cited by this paper
• Peripheral Chemokine Receptors, Their Ligands, Cytokines and Alzheimer's Disease

  2008cited by this paper
• Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.

  2008cited by this paper
• Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.

  2008cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007cited by this paper
• Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats.

  2007cited by this paper
• Testosterone and cognition in normal aging and Alzheimer's disease: an update.

  2007cited by this paper
• IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.

  2007cited by this paper
• Antiinflammatory and Antiatherogenic Effects of the NF-&kgr;B Inhibitor Acetyl-11-Keto-β-Boswellic Acid in LPS-Challenged ApoE−/− Mice

  2007cited by this paper
• Glial cell dysregulation: a new perspective on Alzheimer disease

  2007cited by this paper
• Blood inflammatory markers and risk of dementia: The Conselice Study of Brain Aging.

  2007cited by this paper
• Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.

  2006cited by this paper
• Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!

  2006cited by this paper
• Ageing and neuronal vulnerability

  2006cited by this paper
• Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.

  2006cited by this paper
• Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

  2005cited by this paper
• Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases1

  2005cited by this paper
• Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions.

  2005cited by this paper
• Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture.

  2005cited by this paper
• NF-κB precursor, p105, and NF-κB inhibitor, IκBγ, are both elevated in Alzheimer disease brain

  2005cited by this paper
• A focus on the synapse for neuroprotection in Alzheimer disease and other dementias

  2004cited by this paper
• Protective effect of L-cysteine and glutathione on the modulated suckling rat brain Na+, K+, -ATPase and Mg2+ -ATPase activities induced by the in vitro galactosaemia.

  2004cited by this paper
• The importance of neuritic plaques and tangles to the development and evolution of AD

  2004cited by this paper
• Arachidonic acid‐induced carbon‐centered radicals and phospholipid peroxidation in cyclo‐oxygenase‐2‐transfected PC12 cells

  2004cited by this paper
• Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain

  2004cited by this paper
• Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.

  2004cited by this paper
• Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

  2004cited by this paper
• Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau

  2004cited by this paper
• Neuropathologic changes in Alzheimer's disease.

  2003cited by this paper
• Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.

  2003cited by this paper
• Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders

  2003cited by this paper
• Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain.

  2003cited by this paper
• Rivastigmine blocks voltage‐activated K+ currents in dissociated rat hippocampal neurons

  2003cited by this paper
• Inflammation markers in relation to cognition in a healthy aging population.

  2003cited by this paper
• Screening for acetylcholinesterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies.

  2003cited by this paper
• Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice

  2002cited by this paper
• Aluminum: impacts and disease.

  2002cited by this paper
• Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons

  2001cited by this paper
• Proteasome inhibition in cancer: development of PS-341.

  2001cited by this paper
• Study of alkaloids from Adhatoda vasica Nees on their antiinflammatory activity

  2001cited by this paper
• Inflammatory factors are elevated in brain microvessels in Alzheimer's disease.

  2001cited by this paper
• Blood sampling from the retro-orbital plexus, the saphenous vein and the tail vein in rats: comparative effects on selected behavioural and blood variables

  2001cited by this paper
• Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death.

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Enhanced expression of I-κB with neurofibrillary pathology in Alzheimer's disease

  2001cited by this paper
• Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

  2000cited by this paper
• Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells.

  2000cited by this paper
• Inhibition of Alzheimer's β-Amyloid Induced Vasoactivity and Proinflammatory Response in Microglia by a cGMP-Dependent Mechanism

  1999cited by this paper
• Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium.

  1998cited by this paper
• Effect of Aluminum on Acetyl‐CoA and Acetylcholine Metabolism in Nerve Terminals

  1998cited by this paper
• Bcl-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up.

  1996cited by this paper
• Aluminum-sensitive degradation of amyloid beta-protein 1-40 by murine and human intracellular enzymes.

  1996cited by this paper
• Molecular and cellular biology of cholinesterases.

  1993cited by this paper
• Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.

  1992cited by this paper
• Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease.

  1991cited by this paper
• Theory and Practice of Histological Techniques

  1990cited by this paper
• The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes.

  1988cited by this paper
• Biochemical studies on rabbits with aluminium induced neurofilament accumulations

  1985cited by this paper
• [Cholinesterase (EC 3.1.1.8) with butyrylthiocholine-iodide as substrate: references depending on age and sex with special reference to hormonal effects and pregnancy].

  1983cited by this paper
• introduction to radioimmunoassay and related techniques

  1982cited by this paper
• Experimental study of biological effects of leads and aluminum following oral administration.

  1979cited by this paper
• Principles of medicinal chemistry

  1974cited by this paper
• EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION: 1. LIGHT MICROSCOPIC OBSERVATIONS

  1965cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Exploring boswellic acids as a multitarget therapeutic treatment for Alzheimer’s disease

  2026cites this paper
• Preparation and characterization of brain-targeted polymeric nanocarriers (Frankincense-PMBN-lactoferrin) and in-vivo evaluation on an Alzheimer's disease-like rat model induced by scopolamine.

  2023cites this paper
• Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease

  2020cites this paper
• Genus Boswellia as a new candidate for neurodegenerative disorders

  2020cites this paper
• Acute aluminum chloride toxicity revisited: Study on DNA damage and histopathological, biochemical and neurochemical alterations in rat brain

  2019cites this paper
• Polyphenol-rich Boswellia serrata gum prevents cognitive impairment and insulin resistance of diabetic rats through inhibition of GSK3β activity, oxidative stress and pro-inflammatory cytokines.

  2019cites this paper
• Protective Effect of Boswellia carteri on Aluminium Chloride-Induced Alzheimer's Disease in Male Albino Rat

  2019cites this paper
• Investigating Quantitative analysis of the gene expression of calcium/calmodulin-dependent protein kinase IV by the effect of Olibanum alcoholic extract in PC12 cell line

  2018cites this paper
• Role of 3-Acetyl-11-Keto-Beta-Boswellic Acid in Counteracting LPS-Induced Neuroinflammation via Modulation of miRNA-155

  2017cites this paper
• Frankincense improves memory retrieval in rats treated with Lipopolysaccharide

  2016cites this paper
• Aqueous and Ethanolic Extracts of Boswellia serrata Protect Against Focal Cerebral Ischemia and Reperfusion Injury in Rats

  2016cites this paper